一天中不同时间对二甲双胍药代动力学的显著影响
本研究利用大型临床数据集,采用经验性与机制性药代动力学模型,探讨人体二甲双胍药代动力学是否受一天中不同时间调节。结果发现一天中不同时间对二甲双胍药代动力学有显著影响,观察到的血浆水平最好由肾小球滤过率、肾血浆流量和有机阳离子转运体2活性的节律组合描述,个体间差异部分取决于个体时型。
要点
- 一天中不同时间对二甲双胍药代动力学有显著影响。
- 二甲双胍血浆水平最好由肾小球滤过率、肾血浆流量和有机阳离子转运体2活性的节律组合描述。
- 二甲双胍浓度的大个体间差异最好由影响二甲双胍清除率的个体时型解释。
核心结论
- 二甲双胍的药理学在人体中显著依赖一天中不同时间,由经验性与机制性药代动力学模型确定,节律性肾小球滤过率、肾血浆流量和有机阳离子转运体2调控日内变异。
- 个体间变异部分取决于个体时型,提示昼夜偏好是未来2型糖尿病患者个体化时间调节治疗中一个有趣但迄今未被充分重视的话题。
研究设计与样本
- 对大型临床数据集中个体二甲双胍血浆和尿液测量值,采用新开发的经验性药代动力学模型进行分析。
- 通过文献 informed 的机制性建模分析,进一步研究二甲双胍药代动力学日变异的原因和个体间变异。
主要发现
- 发现一天中不同时间对二甲双胍药代动力学有显著影响。
- 观察到的二甲双胍血浆水平最好由肾小球滤过率、肾血浆流量和有机阳离子转运体2活性的节律组合描述。
- 测得的二甲双胍浓度的大个体间差异最好由影响二甲双胍清除率的个体时型解释,对血浆和组织浓度的影响可能对二甲双胍疗效有提示意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The objective was to investigate if metformin pharmacokinetics is modulated by time-of-day in humans using empirical and mechanistic pharmacokinetic modelling techniques on a large clinical dataset. This study also aimed to generate and test hypotheses on the underlying mechanisms, including evidence for chronotype-dependent interindividual differences in metformin plasma and efficacy-related tissue concentrations. METHODS: A large clinical dataset consisting of individual metformin plasma and urine measurements was analysed using a newly developed empirical pharmacokinetic model. Causes of daily variation of metformin pharmacokinetics and interindividual variability were further investigated by a literature-informed mechanistic modelling analysis. RESULTS: A significant effect of time-of-day on metformin pharmacokinetics was found. Daily rhythms of gastrointestinal, hepatic and renal processes are described in the literature, possibly affecting drug pharmacokinetics. Observed metformin plasma levels were best described by a combination of a rhythm in GFR, renal plasma flow (RPF) and organic cation transporter (OCT) 2 activity. Furthermore, the large interindividual differences in measured metformin concentrations were best explained by individual chronotypes affecting metformin clearance, with impact on plasma and tissue concentrations that may have implications for metformin efficacy. CONCLUSIONS/INTERPRETATION: Metformin's pharmacology significantly depends on time-of-day in humans, determined with the help of empirical and mechanistic pharmacokinetic modelling, and rhythmic GFR, RPF and OCT2 were found to govern intraday variation. Interindividual variation was found to be partly dependent on individual chronotype, suggesting diurnal preference as an interesting, but so-far underappreciated, topic with regard to future personalised chronomodulated therapy in people with type 2 diabetes.
引用
- Türk D, Scherer N, Selzer D, et al. Significant impact of time-of-day variation on metformin pharmacokinetics. Diabetologia. 2023. PMID: 36930251. doi:10.1007/s00125-023-05898-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。